Ice cream makers are repositioning their products as more than just a guilty pleasure. With US sales volumes down 1.5% year-on-year through June 13, brands are betting on smaller portions, more protein, and cleaner labels to keep shoppers interested. The shift comes as the growing use of GLP-1 weight-loss drugs and a broader push toward healthier eating change how Americans think about indulgence.
What's happening in the freezer aisle
According to NielsenIQ, US ice cream sales volumes fell 1.5% compared with the same period last year. But that doesn't mean the category is shrinking in value. Dollar sales actually rose about 2.8% over the past year, according to Circana. In other words, people are buying less ice cream by volume, but they're spending more when they do—likely because they're choosing premium or higher-priced options.
This divergence between volume and dollar sales is a classic sign of a market in transition. Consumers are trading down on quantity but up on quality, or they're simply buying less often. The trend is particularly notable because ice cream has long been seen as a recession-proof comfort food. Now, it's facing a different kind of pressure: a health-conscious consumer armed with prescription appetite suppressants.
The GLP-1 effect
GLP-1 receptor agonists, such as Ozempic and Wegovy, are medications originally developed for type 2 diabetes but now widely used for weight loss. They work by mimicking a hormone that regulates appetite, making users feel fuller faster and for longer. As more Americans take these drugs, their eating habits change—often leading to reduced cravings for high-calorie, high-sugar foods like traditional ice cream.
For ice cream makers, this is a direct challenge. But it's also an opportunity. Brands are responding by reformulating products to appeal to the new mindset. That means smaller portion sizes—think single-serve cups and mini bars—as well as added protein to make treats feel more satiating and less like empty calories. Cleaner labels, with fewer artificial ingredients and more recognizable components, are also becoming a selling point.
This isn't just a niche play. Major players like Unilever (which owns Ben & Jerry's and Magnum) and Nestlé (which makes Häagen-Dazs under license) are all adjusting their portfolios. Smaller, premium brands are also leaning into the wellness angle, marketing their products as a better-for-you alternative to traditional ice cream.
What it means for investors
For everyday investors, this trend is a reminder that consumer preferences can shift quickly, and companies that adapt tend to fare better. The ice cream category is a small slice of the broader packaged food market, but it's a useful barometer for how health trends are reshaping even the most indulgent categories.
If you own shares in companies that make ice cream, watch how they're responding. Are they introducing new products with protein or lower sugar? Are they investing in marketing that emphasizes wellness? Those moves could signal whether they're positioned to hold onto market share as GLP-1 use grows.
On the flip side, the rise of GLP-1 drugs has broader implications for the entire food and beverage sector. Companies that sell high-calorie snacks, sugary drinks, and other indulgent foods could face headwinds if the drugs become even more widespread. Conversely, companies that pivot toward healthier options—or that make the drugs themselves—could benefit.
It's also worth noting that the ice cream market's resilience in dollar terms suggests that consumers are still willing to pay for treats, even if they're buying less. That's a positive sign for premium brands that can justify higher prices.
Looking ahead
The next few quarters will be telling. If GLP-1 prescriptions continue to climb, expect more innovation in the freezer aisle—and possibly more pressure on traditional ice cream sales. But if the wellness trend fades, or if consumers decide that a smaller portion isn't worth the price, the market could swing back.
For now, the message from ice cream makers is clear: indulgence and health are no longer opposites. They're just two sides of the same scoop.
